Login/Sign Up
Dobyumin 250 mg Injection 5 ml belongs to a class of medicines called vasopressors used to treat patients with low cardiac output, decompensated heart failure (DHF), and Myocardial infarction (MI). Myocardial infarction, also known as a heart attack, could occur due to the lack of blood and oxygen supply to the heart. Cardiac decompensation is an abnormal condition in which the heart is no longer able to maintain efficient circulation.
Dobyumin 250 mg Injection 5 ml contains Dobutamine which works by increasing blood flow to the muscles and increasing the pumping efficiency of the heart.
Dobyumin 250 mg Injection 5 ml will be administered by a healthcare professional. Hence, do not self-administer. Sometimes, Dobyumin 250 mg Injection 5 ml may cause common side effects such as headache, nausea, shortness of breath, chest pain, irregular heartbeat and pain at the site of injection. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
If you are allergic to Dobutamine or other ingredients of Dobyumin 250 mg Injection 5 ml, please inform your doctor. If you are pregnant or breastfeeding or have a history of blood circulation problems, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml. Dobyumin 250 mg Injection 5 ml is not recommended for children as safety and effectiveness are not established.
Dobyumin 250 mg Injection 5 ml contains Dobutamine which is used to treat Cardiac decompensation and low cardiac output patients. It works by increasing blood flow to the muscles. Additionally, it may be used in people with congestive heart failure (heart failure due to the build-up of blood or fluid) to help the heart pump better by increasing the pumping efficiency of the heart.
If you are allergic to Dobutamine or any other ingredients of Dobyumin 250 mg Injection 5 ml, please tell your doctor. Dobyumin 250 mg Injection 5 ml is not recommended for children as safety and effectiveness were not established. If you are pregnant or breastfeeding, please inform your doctor before receiving Dobyumin 250 mg Injection 5 ml. If you have a history of blood circulation problems, inform your doctor, as you will be monitored for any changes in the colour or temperature of your fingers or toes. If you experience any pain or swelling at the injection site during or immediately after the injection, inform your doctor immediately so that appropriate treatment may be given.
Drug-Drug Interactions: Caution should be maintained if you are taking beta-blockers (propranolol, metoprolol), anticonvulsants (phenytoin), antipsychotics (Amoxapine), anti-depressants (e.g. amitriptyline, clomipramine, imipramine, nortriptyline) inform your doctor before receiving Dobyumin 250 mg Injection 5 ml.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Avoid receiving Dobyumin 250 mg Injection 5 ml if you have hyperthyroidism (overactive thyroid gland), irregular or rapid heartbeats or a tumour that causes an increase in blood pressure. If you have a history of blood circulation problems or have diabetes, high blood pressure, Raynaud’s disease (fingers become white and very painful when cold), or liver or kidney problems, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml.
Myocardial infarction (MI)/Heart attack: It occurs when a blood clot blocks the blood flow to the heart. This blockage of arteries is often an accumulation of fat, cholesterol and other substances, which form plaque in the arteries that feed the heart (coronary arteries). Heart attack signs include chest pain, upper body pain, sweating, nausea, fatigue, and trouble breathing.
Decompensated heart failure (DHF): It is a condition in which the heart is no longer able to maintain efficient circulation. This leads to the sudden onset of symptoms of heart failure.
About Dobyumin 250 mg Injection 5 ml
Dobyumin 250 mg Injection 5 ml belongs to a class of medicines called vasopressors used to treat patients with low cardiac output, decompensated heart failure (DHF), and Myocardial infarction (MI). Myocardial infarction, also known as a heart attack, could occur due to the lack of blood and oxygen supply to the heart. Cardiac decompensation is an abnormal condition in which the heart is no longer able to maintain efficient circulation.
Dobyumin 250 mg Injection 5 ml contains Dobutamine which works by increasing blood flow to the muscles and increasing the pumping efficiency of the heart.
Dobyumin 250 mg Injection 5 ml will be administered by a healthcare professional. Hence, do not self-administer. Sometimes, Dobyumin 250 mg Injection 5 ml may cause common side effects such as headache, nausea, shortness of breath, chest pain, irregular heartbeat and pain at the site of injection. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
If you are allergic to Dobutamine or other ingredients of Dobyumin 250 mg Injection 5 ml, please inform your doctor. If you are pregnant or breastfeeding or have a history of blood circulation problems, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml. Dobyumin 250 mg Injection 5 ml is not recommended for children as safety and effectiveness are not established.
₹47.3*
₹40.2*
MRP ₹47.3
15% CB
₹7.1 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Available Offers
Country of origin
Manufacturer/Marketer address
Dobyumin 250 mg Injection 5 ml contains Dobutamine which works by increasing blood flow to the muscles and increasing the pumping efficiency of the heart.
Dobyumin 250 mg Injection 5 ml should be used with caution in diabetic patients as it may cause Dobutamine stress echocardiography. Therefore, if you have diabetes, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml.
Alcohol
Caution
Avoid consumption of alcohol. Please discuss with your doctor if you have concerns.
Pregnancy
Caution
Dobyumin 250 mg Injection 5 ml is considered safe to be used in pregnancy. However, if you are pregnant or planning pregnancy, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml.
Breast Feeding
Caution
Limited data are available on the effect of Dobyumin 250 mg Injection 5 ml on breastfeeding. Hence, if you are a nursing mother, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml.
Driving
Not applicable
Dobyumin 250 mg Injection 5 ml is generally intended for use in hospitalized patients.
Liver
Caution
If you have liver problems, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml. Your doctor may adjust the dose of this medicine if necessary or prescribe a suitable alternative based on your condition.
Kidney
Caution
If you have kidney problems, inform your doctor before receiving Dobyumin 250 mg Injection 5 ml. Your doctor may adjust the dose of this medicine if necessary or prescribe a suitable alternative based on your condition.
Children
Unsafe
Dobyumin 250 mg Injection 5 ml is not recommended for children as safety and effectiveness were not established in children.
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Uses of Dobyumin 250 mg Injection 5 ml
Medicinal Benefits
Dobyumin 250 mg Injection 5 ml contains Dobutamine which is used to treat Cardiac decompensation and low cardiac output patients. It works by increasing blood flow to the muscles. Additionally, it may be used in people with congestive heart failure (heart failure due to the build-up of blood or fluid) to help the heart pump better by increasing the pumping efficiency of the heart.
Side Effects of Dobyumin 250 mg Injection 5 ml
Directions for Use
Storage
Drug Warnings
If you are allergic to Dobutamine or any other ingredients of Dobyumin 250 mg Injection 5 ml, please tell your doctor. Dobyumin 250 mg Injection 5 ml is not recommended for children as safety and effectiveness were not established. If you are pregnant or breastfeeding, please inform your doctor before receiving Dobyumin 250 mg Injection 5 ml. If you have a history of blood circulation problems, inform your doctor, as you will be monitored for any changes in the colour or temperature of your fingers or toes. If you experience any pain or swelling at the injection site during or immediately after the injection, inform your doctor immediately so that appropriate treatment may be given.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Myocardial infarction (MI)/Heart attack: It occurs when a blood clot blocks the blood flow to the heart. This blockage of arteries is often an accumulation of fat, cholesterol and other substances, which form plaque in the arteries that feed the heart (coronary arteries). Heart attack signs include chest pain, upper body pain, sweating, nausea, fatigue, and trouble breathing.
Decompensated heart failure (DHF): It is a condition in which the heart is no longer able to maintain efficient circulation. This leads to the sudden onset of symptoms of heart failure.
by Others
by Others